If you’ve ever turned on the TV, scrolled through social media, or flipped through a magazine, you’ve likely seen a steady stream of advertisements for medications like Restasis, Ozempic, Vraylar, Eliquis, Farxiga, Linzess, Jardiance, and Taltz. These medications promise relief from chronic conditions, improved quality of life, and better health outcomes. But they come with a hefty price tag, and for many companies providing healthcare benefits, these high-cost medications are wreaking havoc on their bottom lines.

The problem is simple: corporate healthcare plans—often fully insured, cookie-cutter packages—are struggling to absorb the escalating costs of prescription drugs. Employers are shouldering more of the financial burden, passing rising premiums down to employees, while employees face increasingly steep out-of-pocket costs just to maintain their prescribed treatments. 

The result? Less access, lower adherence, and worse outcomes. It’s a vicious cycle.

And if you’re a member of a corporate sector – whether an employer or an employee – there’s only one way of escaping it. 

You make your own plan, with your own rules.

That’s what Better Source Benefits designs for the clients. These solutions don’t just shift the cost of healthcare—they change how it’s managed, creating opportunities for both employers and employees to save significantly, especially when it comes to high-cost medications.

Through carefully structured, deeply discounted arrangements, our custom self-funded healthcare plans allow employers to secure medications like the ones you see advertised for far less. And when we say “far less,” we don’t just mean a small percentage difference—we mean significant cost reductions that can take a meaningful chunk out of an employer’s healthcare expenses.

Let me give you just a couple of examples from our list: 

  • Glatopa: $0 instead of $750
  • Relistor: $0.00 instead of $2,314.97
  • Traltz: $0.00 instead of $6,482.52
  • Trulance: $0.00 instead of $549.31
  • Envarsus: $0.00 instead of $374.04
  • Restasis: $854 instead of $1,956.90
  • Ozempi: $1,485.00 instead of $2,719.62
  • Tradjenta: $314 instead of $1,550.70
  • Vraylar: $1,309.99 instead of $4,413.60
  • Flowent: $226.98 instead of $1,253.25

…. And that’s only the tip of the iceberg.  

I know that every employer reading this, is impressed already. But what’s truly revolutionary is how these plans can benefit employees.

We’re not just talking about lower co-pays or reduced premiums. With our solution, employees can often access these expensive medications at no cost to them. That’s right—free

Imagine getting a 90-day supply of your prescribed medication without having to worry about how much it’s going to cut into your paycheck or impact your monthly budget. Our plans make that a reality by eliminating the cost to employees while still maintaining high-quality coverage.

Access to medications for chronic conditions without financial barriers can improve patient adherence, which is crucial in managing long-term health conditions like diabetes, heart disease, mental health disorders, and autoimmune diseases. When employees can stick to their treatments without interruptions, they see better results.

That means fewer hospital visits, fewer complications, and less time spent navigating the healthcare system.